Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Platelet to high-density lipoprotein cholesterol ratio predicts clinical outcomes after acute ischemic stroke: a prospective cohort study.

Frontiers in neurology·2026
Same author

Cell-type signatures of Alzheimer's disease shared across population groups.

Nature·2026
Same author

Sex Differences in the Association of Simultaneous Decline in Blood Pressure and Decline in Cognition during Aging.

Annals of neurology·2026
Same author

Depleting prion protein using splice-switching small molecules.

bioRxiv : the preprint server for biology·2026
Same author

Evaluation of potential serum biomarkers for individuals at risk of multiple sclerosis.

bioRxiv : the preprint server for biology·2026
Same author

Improved heritability partitioning and enrichment analyses using summary statistics with graphREML.

Nature genetics·2026

Related Experiment Video

Updated: Jun 4, 2026

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging
09:37

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging

Published on: July 14, 2016

8.2K

Integrative multi-omics QTL colocalization maps regulatory architecture in aging human brain.

Xuewei Cao1,2, Haochen Sun1,2, Ru Feng1

  • 1Center for Statistical Genetics, The Gertrude H. Sergievsky Center, Columbia University, New York, NY, USA.

Medrxiv : the Preprint Server for Health Sciences
|May 19, 2025
PubMed
Summary

ColocBoost, a new multi-task learning method, efficiently integrates large-scale multi-omics data for genetic studies. It identifies shared genetic signals across many traits, improving insights into complex diseases like Alzheimer's disease.

More Related Videos

Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration
04:41

Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration

Published on: January 9, 2020

18.9K
Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

931

Related Experiment Videos

Last Updated: Jun 4, 2026

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging
09:37

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging

Published on: July 14, 2016

8.2K
Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration
04:41

Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration

Published on: January 9, 2020

18.9K
Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

931

Area of Science:

  • Genomics
  • Computational Biology
  • Statistical Genetics

Background:

  • Multi-trait QTL (xQTL) colocalization identifies shared genetic etiology across molecular data and diseases.
  • Integrating large-scale multi-omics data for xQTL regulation insights is limited by current methods' scalability and efficiency.

Purpose of the Study:

  • To develop a scalable and efficient multi-task learning method, ColocBoost, for multi-trait QTL colocalization.
  • To enhance the detection of shared genetic signals and causal variants by accounting for multiple causal variants and adaptively coupling traits.

Main Methods:

  • ColocBoost utilizes a specialized gradient boosting framework for multi-task learning.
  • The method is applied genome-wide to 17 gene-level xQTL datasets from aging brain cortex (ROSMAP), covering multiple cell types, brain regions, and molecular modalities (expression, splicing, protein abundance).

Main Results:

  • ColocBoost identified 16,503 distinct colocalization events, showing a 10.7-fold enrichment for heritability across 57 complex diseases/traits.
  • It demonstrated strong concordance with CRISPR-validated element-gene pairs and identified 2.5-fold more Alzheimer's disease (AD) colocalized loci, explaining twice the AD heritability.
  • The method enhanced detection of gene-distal colocalizations, aligning with known enhancer-gene links and providing functional support for genes like BLNK and CTSH in AD pathogenesis.

Conclusions:

  • ColocBoost offers a scalable and efficient approach for multi-trait QTL colocalization, advancing the integration of multi-omics data.
  • The method significantly improves the identification of shared genetic signals and causal variants, particularly for complex diseases like AD.
  • ColocBoost provides novel functional insights into disease susceptibility loci and underlying regulatory mechanisms.